Arcus Biosciences (RCUS) issued a press release on August 5, 2026, reporting its financial results for the six months ended June 30, 2026. The company disclosed this via an 8-K, with the press release included as Exhibit 99.1. The excerpt doesn't include any actual numbers, so it mainly confirms that the earnings announcement was made and furnished to regulators.
View Full Filing (SEC EDGAR)